{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:05:37Z","timestamp":1773115537236,"version":"3.50.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","annalsofvascularsurgery.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.avsg.2024.06.013","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T19:22:30Z","timestamp":1721071350000},"page":"35-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A Bibliometric Analysis on Adherence to Reporting Standards for Endovascular Treatment of Chronic Lower Extremity Peripheral Artery Disease"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7232-1813","authenticated-orcid":false,"given":"Neal","family":"Modi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Timmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aberdeen","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saideep","family":"Bose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Smeds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2024.06.013_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/2046-4053-1-60","article-title":"Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review","volume":"1","author":"Turner","year":"2012","journal-title":"Syst Rev"},{"key":"10.1016\/j.avsg.2024.06.013_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065442","article-title":"Reporting quality of social and psychological intervention trials: a systematic review of reporting guidelines and trial publications","volume":"8","author":"Grant","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.avsg.2024.06.013_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jdent.2015.01.006","article-title":"Use of guidelines to improve the quality and transparency of reporting oral health research","volume":"43","author":"Sarkis-Onofre","year":"2015","journal-title":"J Dent"},{"key":"10.1016\/j.avsg.2024.06.013_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011082","article-title":"Reporting quality of randomised controlled trial abstracts among high-impact general medical journals: a review and analysis","volume":"6","author":"Hays","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.avsg.2024.06.013_bib5","article-title":"State of reporting of primary biomedical research: a scoping review protocol","volume":"7","author":"Li","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.avsg.2024.06.013_bib6","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.apmr.2022.01.156","article-title":"Completeness of reporting is suboptimal in randomized controlled trials published in rehabilitation journals, with trials with low risk of bias displaying better reporting: a meta-research study","volume":"103","author":"Innocenti","year":"2022","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.avsg.2024.06.013_bib7","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/jnci\/djs259","article-title":"Quality of reporting of modern randomized controlled trials in medical oncology: a systematic review","volume":"104","author":"P\u00e9ron","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.avsg.2024.06.013_bib8","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1200\/JCO.2013.49.3981","article-title":"Adherence to CONSORT adverse event reporting guidelines in randomized clinical trials evaluating systemic cancer therapy: a systematic review","volume":"31","author":"P\u00e9ron","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.avsg.2024.06.013_bib9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4104\/pcrj.2013.00089","article-title":"The quality of reporting of randomised controlled trials in asthma: a systematic review","volume":"22","author":"Ntala","year":"2013","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.avsg.2024.06.013_bib10","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/DSS.0000000000000902","article-title":"A systematic review of completeness of reporting in randomized controlled trials in dermatologic surgery: adherence to CONSORT 2010 recommendations","volume":"42","author":"Alam","year":"2016","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.avsg.2024.06.013_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13643-017-0527-2","article-title":"Systematic review adherence to methodological or reporting quality","volume":"6","author":"Pussegoda","year":"2017","journal-title":"Syst Rev"},{"key":"10.1016\/j.avsg.2024.06.013_bib12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/XEB.0000000000000135","article-title":"Reporting guideline and clinical trial registration requirements in gastroenterology and hepatology journals","volume":"16","author":"Jorski","year":"2018","journal-title":"Int J Evid Based Healthc"},{"key":"10.1016\/j.avsg.2024.06.013_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12873-019-0233-6","article-title":"Quality of reporting of systematic reviews and meta-analyses in emergency medicine based on the PRISMA statement","volume":"19","author":"Nawijn","year":"2019","journal-title":"BMC Emerg Med"},{"key":"10.1016\/j.avsg.2024.06.013_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-031259","article-title":"Endorsement of reporting guidelines and study registration by endocrine and internal medicine journals: meta-epidemiological study","volume":"9","author":"Zu\u00f1iga-Hernandez","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.avsg.2024.06.013_bib15","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/ajcp\/aqaa103","article-title":"Compliance with standards for STARD 2015 reporting recommendations in pathology","volume":"154","author":"Hogan","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.avsg.2024.06.013_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jclinepi.2020.12.020","article-title":"A review found inadequate reporting of case-control studies of risk factors for pancreatic cancer","volume":"133","author":"MacCarthy","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.avsg.2024.06.013_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jclinepi.2022.07.002","article-title":"Adherence to the PRISMA-P 2015 reporting guideline was inadequate in systematic review protocols","volume":"150","author":"Frost","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.avsg.2024.06.013_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejvs.2023.08.066","article-title":"Exploring the reporting standards of randomised controlled trials involving endovascular interventions for peripheral arterial disease: a systematic review","volume":"67","author":"Zywicka","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2024.06.013_bib19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/ajcp\/aqx080","article-title":"A Survey of the prevalence and impact of reporting guideline endorsement in pathology journals","volume":"148","author":"Caron","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.avsg.2024.06.013_bib20","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jvs.2016.03.420","article-title":"Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease","volume":"64","author":"Stoner","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.06.013_bib21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jcin.2022.01.001","article-title":"The impact of intravascular ultrasound on femoropopliteal artery endovascular interventions: a randomized controlled trial","volume":"15","author":"Allan","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2024.06.013_bib22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/1526602820965965","article-title":"Heparin-Bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: 36-month results of the viabahn 25 cm trial","volume":"28","author":"B\u00f6hme","year":"2021","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2024.06.013_bib23","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.jvs.2021.04.057","article-title":"Promise I: early feasibility study of the LimFlow System for percutaneous deep vein arterialization in no-option chronic limb-threatening ischemia: 12-month results","volume":"74","author":"Clair","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.06.013_bib24","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jvs.2020.08.135","article-title":"Six-month pivotal results of tack optimized balloon angioplasty using the Tack Endovascular System in below-the-knee arteries","volume":"73","author":"Geraghty","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.06.013_bib25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/1708538120953663","article-title":"Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: an additional analysis from the AcoArt I study","volume":"29","author":"Sun","year":"2021","journal-title":"Vascular"},{"key":"10.1016\/j.avsg.2024.06.013_bib26","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00270-021-02901-6","article-title":"24-Month efficacy and safety results from Japanese patients in the IMPERIAL randomized study of the eluvia drug-eluting stent and the zilver PTX drug-coated stent","volume":"44","author":"Iida","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2024.06.013_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1526602820969681","article-title":"Drug-Coated balloon angioplasty compared with uncoated balloons in the treatment of infrapopliteal artery lesions (AcoArt II-BTK)","volume":"28","author":"Jia","year":"2021","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2024.06.013_bib28","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/17085381211013968","article-title":"Orchid drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of femoropopliteal artery disease: 12-month result of the randomized controlled trial","volume":"30","author":"Liao","year":"2022","journal-title":"Vascular"},{"key":"10.1016\/j.avsg.2024.06.013_bib29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00270-022-03104-3","article-title":"Drug-eluting balloon for below the knee angioplasty: five-year outcome of the DEBATE-BTK randomized clinical trial","volume":"45","author":"Liistro","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2024.06.013_bib30","doi-asserted-by":"crossref","first-page":"e1445","DOI":"10.4244\/EIJ-D-21-00444","article-title":"Paclitaxel-coated balloons versus percutaneous transluminal angioplasty for infrapopliteal chronic total occlusions: the IN.PACT BTK randomised trial","volume":"17","author":"Liistro","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.avsg.2024.06.013_bib31","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00270-020-02693-1","article-title":"Two-year efficacy and safety results from the IMPERIAL randomized study of the eluvia polymer-coated drug-eluting stent and the zilver PTX polymer-free drug-coated stent","volume":"44","author":"M\u00fcller-H\u00fclsbeck","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2024.06.013_bib32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/1358863X20988360","article-title":"Microcrystalline paclitaxel-coated balloon for revascularization of femoropopliteal artery disease: three-year outcomes of the randomized BIOPAC trial","volume":"26","author":"Nowakowski","year":"2021","journal-title":"Vasc Med"},{"key":"10.1016\/j.avsg.2024.06.013_bib33","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jvs.2021.05.056","article-title":"Long-term results of the Japanese multicenter Viabahn trial of heparin bonded endovascular stent grafts for long and complex lesions in the superficial femoral artery","volume":"74","author":"Ohki","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.06.013_bib34","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1148\/radiol.2021204294","article-title":"Randomized controlled trial comparing drug-coated balloon angioplasty versus conventional balloon angioplasty for treating below-the-knee arteries in critical limb ischemia: the SINGA-PACLI trial","volume":"300","author":"Patel","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.avsg.2024.06.013_bib35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jvs.2021.07.232","article-title":"Procedural and 12-month in-hospital costs of primary infra-popliteal bypass surgery, infrapopliteal best endovascular treatment, and major lower limb amputation for chronic limb threatening ischemia","volume":"75","author":"Popplewell","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.06.013_bib36","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.010280","article-title":"Atherectomy and drug-coated balloon angioplasty for the treatment of long infrapopliteal lesions: a randomized controlled trial","volume":"14","author":"Rastan","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2024.06.013_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211006546","article-title":"Association between post-balloon angioplasty dissection and primary patency in complex femoropopliteal artery disease: 2-year clinical outcomes of the AcoArt I trial","volume":"49","author":"Ren","year":"2021","journal-title":"J Int Med Res"},{"key":"10.1016\/j.avsg.2024.06.013_bib38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jvs.2022.02.019","article-title":"A prospective randomized trial on endovascular recanalization with stenting versus remote endarterectomy for the superficial femoral artery total occlusive lesions","volume":"76","author":"Saaya","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.06.013_bib39","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jcin.2021.03.021","article-title":"1-Year results from the RANGER II SFA randomized trial of the ranger drug-coated balloon","volume":"14","author":"Sachar","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2024.06.013_bib40","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/VHRM.S371177","article-title":"Jetstream atherectomy followed by paclitaxel-coated balloons versus balloon angioplasty followed by paclitaxel-coated balloons: Twelve-month exploratory results of the prospective randomized JET-RANGER study","volume":"18","author":"Shammas","year":"2022","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.avsg.2024.06.013_bib41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jvir.2020.09.003","article-title":"Randomized, double-blind, placebo-controlled trial to evaluate safety and Therapeutic efficacy of angiogenesis induced by intraarterial autologous bone marrow-derived stem cells in patients with severe peripheral arterial disease","volume":"32","author":"Sharma","year":"2021","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.avsg.2024.06.013_bib42","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1161\/CIRCULATIONAHA.122.059646","article-title":"Randomized trial of chocolate Touch compared with lutonix drug-coated balloon in femoropopliteal lesions (chocolate Touch study)","volume":"145","author":"Shishehbor","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.06.013_bib43","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00380-021-01947-3","article-title":"One-year results for Japanese patients in RANGER II SFA","volume":"37","author":"Soga","year":"2022","journal-title":"Heart Ves"},{"key":"10.1016\/j.avsg.2024.06.013_bib44","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ejvs.2022.02.002","article-title":"Editor's choice - hybrid vs. Open surgical reconstruction for iliofemoral occlusive disease: a prospective randomised trial","volume":"63","author":"Starodubtsev","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2024.06.013_bib45","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/1526602820980419","article-title":"Treatment of femoropopliteal lesions with the BioMimics 3D vascular stent system: two-year results from the MIMICS-2 trial","volume":"28","author":"Sullivan","year":"2021","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2024.06.013_bib46","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/15266028211007457","article-title":"World's first experience treating TASC II C and D Tibial occlusive disease using the selution SLR sirolimus-eluting balloon: six-month results from the PRESTIGE study","volume":"28","author":"Tang","year":"2021","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2024.06.013_bib47","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jcin.2021.04.010","article-title":"Intravascular lithotripsy for peripheral artery calcification: 30-day outcomes from the randomized disrupt PAD III trial","volume":"14","author":"Tepe","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2024.06.013_bib48","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jvs.2021.01.041","article-title":"Long-term safety and efficacy of angioplasty of femoropopliteal artery disease with drug-coated balloons from the AcoArt I trial","volume":"74","author":"Xu","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.06.013_bib49","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijcard.2020.10.060","article-title":"Reewarm\u2122 PTX drug-coated balloon in the treatment of femoropopliteal artery disease: a multi-center, randomized controlled trial in China","volume":"326","author":"Ye","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.avsg.2024.06.013_bib50","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jvir.2020.01.004","article-title":"Three-year efficacy and safety of the misago peripheral stent for superficial femoral artery disease: final results from the OSPREY trial","volume":"31","author":"Angle","year":"2020","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.avsg.2024.06.013_bib51","doi-asserted-by":"crossref","first-page":"617","DOI":"10.23736\/S0021-9509.20.11382-X","article-title":"Stent-grafts are the best way to treat complex in-stent restenosis lesions in the superficial femoral artery: 24-month results from a multicenter randomized trial","volume":"61","author":"Bosiers","year":"2020","journal-title":"J Cardiovasc Surg"},{"key":"10.1016\/j.avsg.2024.06.013_bib52","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/1526602820902014","article-title":"ZILVERPASS study: ZILVER PTX stent vs bypass surgery in femoropopliteal lesions","volume":"27","author":"Bosiers","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2024.06.013_bib53","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.jvs.2020.01.078","article-title":"Optimized drug-coated balloon angioplasty of the superficial femoral and proximal popliteal arteries using the Tack Endovascular System: TOBA III 12-month results","volume":"72","author":"Brodmann","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.06.013_bib54","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.avsg.2019.06.014","article-title":"Midterm outcome of directional atherectomy combined with drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal arteriosclerosis obliterans","volume":"64","author":"Cai","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2024.06.013_bib55","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00270-019-02324-4","article-title":"Paclitaxel-Coated zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality compared to uncoated devices","volume":"43","author":"Dake","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2024.06.013_bib56","article-title":"Absence of long-term benefit of revascularization in patients with intermittent claudication: five-year results from the IRONIC randomized controlled trial","volume":"13","author":"Djerf","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2024.06.013_bib57","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jcin.2019.12.028","article-title":"A polymer-free paclitaxel-eluting stent versus a bare-metal stent for de novo femoropopliteal lesions: the BATTLE trial","volume":"13","author":"Gou\u00ebffic","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2024.06.013_bib58","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/1526602820901723","article-title":"Effectiveness and safety of a paclitaxel-eluting stent for superficial femoral artery lesions up to 190 mm: one-year outcomes of the single-arm IMPERIAL long lesion substudy of the eluvia drug-eluting stent","volume":"27","author":"Golzar","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2024.06.013_bib59","first-page":"243","article-title":"PACT all-subjects one-year analysis and standard vs broader implications","volume":"32","author":"Kobe","year":"2020","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.avsg.2024.06.013_bib60","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ejvs.2020.06.042","article-title":"Editor's choice - relationship between global limb anatomic staging system (GLASS) and clinical outcomes following revascularisation for chronic limb threatening ischaemia in the bypass versus angioplasty in severe ischaemia of the leg (BASIL)-1 trial","volume":"60","author":"Kodama","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2024.06.013_bib61","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jvir.2020.05.012","article-title":"Sex-related differences in the long-term outcomes of patients with femoropopliteal arterial disease treated with the IN.PACT drug-coated balloon in the IN.PACT SFA randomized controlled trial: a post hoc analysis","volume":"31","author":"Kohi","year":"2020","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.avsg.2024.06.013_bib62","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00270-020-02602-6","article-title":"10-Year paclitaxel dose-related outcomes of drug-eluting stents treated below the knee in patients with chronic limb-threatening ischemia (the PADI trial)","volume":"43","author":"Konijn","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2024.06.013_bib63","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.jvs.2020.02.043","article-title":"One-year results from the DETOUR I trial of the PQ Bypass DETOUR System for percutaneous femoropopliteal bypass","volume":"72","author":"Krievins","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.06.013_bib64","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12872-020-01356-w","article-title":"One-year results of drug-coated balloons for long and occlusive Femoropopliteal artery disease: a single-arm trial","volume":"20","author":"Lai","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.avsg.2024.06.013_bib65","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jcin.2020.06.045","article-title":"Randomized controlled trial of acotec drug-eluting balloon versus plain balloon for below-the-knee angioplasty","volume":"13","author":"Liistro","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2024.06.013_bib66","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.avsg.2019.10.031","article-title":"The common femoral artery bifurcation lesions: clinical outcome of simple versus complex stenting techniques - an analysis based on the TECCO trial","volume":"64","author":"Nasr","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2024.06.013_bib67","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.avsg.2019.06.035","article-title":"Drug-Coated balloon angioplasty in clinical practice for below-the-knee, popliteal, and crural artery lesions causing critical limb ischemia: 1-year results from the Spanish luminor registry","volume":"62","author":"Riambau","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2024.06.013_bib68","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.avsg.2019.06.038","article-title":"Real-World results of supera stent implantation for popliteal artery atherosclerotic lesions: 3-year outcome","volume":"62","author":"San Norberto","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2024.06.013_bib69","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00270-019-02355-x","article-title":"Japanese patients treated in the IMPERIAL randomized trial comparing eluvia and zilver PTX stents","volume":"43","author":"Soga","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2024.06.013_bib70","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/1526602820948240","article-title":"Three-year results of the IN.PACT SFA Japan trial comparing drug-coated balloons with percutaneous transluminal angioplasty","volume":"27","author":"Soga","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2024.06.013_bib71","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehaa049","article-title":"COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions","volume":"41","author":"Steiner","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.avsg.2024.06.013_bib72","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1148\/radiol.2020191619","article-title":"Drug-coated balloon angioplasty of femoropopliteal lesions maintained superior efficacy over conventional balloon: 2-year results of the randomized EffPac trial","volume":"295","author":"Teichgr\u00e4ber","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.avsg.2024.06.013_bib73","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/1526602820907917","article-title":"Paclitaxel-Coated balloon vs uncoated balloon angioplasty for treatment of in-stent restenosis in the superficial femoral and popliteal arteries: the COPA CABANA trial","volume":"27","author":"Tepe","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2024.06.013_bib74","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jcin.2019.10.059","article-title":"The IN.PACT DEEP clinical drug-coated balloon trial: 5-year outcomes","volume":"13","author":"Zeller","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2024.06.013_bib75","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1471-8847.2012.00324.x","article-title":"US IRBs confronting research in the developing world","volume":"12","author":"Klitzman","year":"2012","journal-title":"Dev World Bioeth"},{"key":"10.1016\/j.avsg.2024.06.013_bib76","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026589","article-title":"Scoping review on interventions to improve adherence to reporting guidelines in health research","volume":"9","author":"Blanco","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.avsg.2024.06.013_bib77","series-title":"Instructions for authors. J Vasc Surg","year":"2023"},{"key":"10.1016\/j.avsg.2024.06.013_bib78","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jvs.2010.11.122","article-title":"Reporting standards for carotid interventions from the society for vascular surgery","volume":"53","author":"Timaran","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.06.013_bib79","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1067\/mva.2002.123763","article-title":"Reporting standards for endovascular aortic aneurysm repair","volume":"35","author":"Chaikof","year":"2002","journal-title":"J Vasc Surg"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509624004242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509624004242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T23:31:36Z","timestamp":1732577496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509624004242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":79,"alternative-id":["S0890509624004242"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2024.06.013","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Bibliometric Analysis on Adherence to Reporting Standards for Endovascular Treatment of Chronic Lower Extremity Peripheral Artery Disease","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2024.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}